Forecasts by Product (Instrument, Reagents, Kits, & Consumables, Software & Services), by Type of Testing (Laboratory Testing and POC Testing), by Technology (Immunodiagnostics, Polymerase Chain Reaction (PCR), DNA Sequencing And Next-Generation Sequencing (NGS), Clinical Microbiology, Other), by Application (COVID-19, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Hepatitis, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other), by End-user (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Home Care Settings, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis
The Infectious Disease Diagnostics Market Report 2022-2032: This report will prove invaluable to leading firms striving for new revenue pockets if they wish to better understand the industry and its underlying dynamics. It will be useful for companies that would like to expand into different industries or to expand their existing operations in a new region.
Growing Prevalence of Infectious Diseases, And Shift in Focus from Centralized Laboratories to Decentralized POC Testing Are Driving the Market Growth Growing prevalence of infectious diseases is anticipated to drive the growth of the infectious disease diagnostics market over the forecast period. For instance, on February 23, 2020, there were 76,936 reported cases in mainland China and 1,875 cases of coronavirus disease 2019 in locations outside mainland China and the number of associated deaths was 2,462.
According to The Joint United Nations Programme on HIV/AIDS (UNAIDS), 37.7 million individuals were HIV positive in 2020, out of which 36 million were adults and 1.7 million were children between the ages of 0 and 14. Furthermore, more than half (53%) were females. 1.5 million new HIV cases were recorded in 2020 worldwide. Further, Hepatitis is a viral infection that results in liver inflammation. Hepatitis viruses come in five primary strains: A, B, C, D, and E. As per the World Health Organization (WHO), about 58 million individuals worldwide have chronic hepatitis C virus infection, and 1.5 million new infections occur each year.
According to WHO, After COVID-19, tuberculosis (TB) is the second most common infectious disease in the world and the thirteenth leading cause of death overall. As per WHO, 1.5 million deaths were caused due to TB in 2020 (including 214,000 people affected by HIV). WHO anticipated that 10 million individuals, including 1.1 million children, 3.3 million women, and 5.6 million men, would be affected by TB worldwide in 2020. All countries and age ranges are affected by TB. In addition, 30 countries with heavy TB burdens accounted for 86% of new TB cases in 2020. Two-thirds of the total is made up of eight countries, with India topping the list, then China, the Philippines, Nigeria, Pakistan, Indonesia, Bangladesh, and South Africa.
Moreover, the growing prevalence of healthcare-acquired infections (HAIs) globally. For instance, according to the Centers for Disease Control (CDC), HAIs alone in American hospitals are considered to be responsible for 1.7 million infections and 99,000 associated deaths per year. Of these infections, urinary tract infections make up 32% of all healthcare-acquired infections, followed by surgical site infections (22%), pneumonia (15%), and bloodstream infections (14%).
Growing prevalence of infectious diseases in developed and emerging nations will positively impact the growth of the infectious disease diagnostics market. The diagnosis and management of these diseases are key responsible factors for the rising number of prescriptions for diagnostic tests for infectious diseases. Large-scale population-based diagnostic testing is required for the prevention and control measures of COVID-19.
What Questions Should You Ask before Buying a Market Research Report? • How is the infectious disease diagnostics market evolving? • What is driving and restraining the infectious disease diagnostics market? • How will each infectious disease diagnostics submarket segment grow over the forecast period and how much revenue will these submarkets account for in 2032? • How will the market shares for each infectious disease diagnostics submarket develop from 2022 to 2032? • What will be the main driver for the overall market from 2022 to 2032? • Will leading infectious disease diagnostics markets broadly follow the macroeconomic dynamics, or will individual national markets outperform others? • How will the market shares of the national markets change by 2032 and which geographical region will lead the market in 2032? • Who are the leading players and what are their prospects over the forecast period? • What are the infectious disease diagnostics research projects for these leading companies? • How will the industry evolve during the period between 2022 and 2032? What are the implications of infectious disease diagnostics projects taking place now and over the next 10 years? • Is there a greater need for product commercialisation to further scale the infectious disease diagnostics market? • Where is the infectious disease diagnostics market heading and how can you ensure you are at the forefront of the market? • What are the best investment options for new product and service lines? • What are the key prospects for moving companies into a new growth path and C-suite?
You need to discover how this will impact the Infectious Disease Diagnostics Market today, and over the next 10 years: • Our Visiongain’s 32-page report provides 120 tables and 201 charts/graphs exclusively to you. • The report highlights key lucrative areas in the industry so you can target them – NOW. • It contains in-depth analysis of global, regional and national sales and growth. • It highlights for you the key successful trends, changes and revenue projections made by your competitors.
This report tells you TODAY how the Infectious Disease Diagnostics Market will develop in the next 10 years, and in line with the variations in COVID-19 economic recession and bounce. This market is more critical now than at any point over the last 10 years.
Forecasts to 2032 and other analyses reveal commercial prospects • In addition to revenue forecasting to 2032, our new study provides you with recent results, growth rates, and market shares. • You will find original analyses, with business outlooks and developments. • Discover qualitative analyses (including market dynamics, drivers, opportunities, restraints and challenges), cost structure, impact of rising infectious disease diagnostics prices and recent developments.
This report includes data analysis and invaluable insight into how COVID-19 will affect the industry and your company. Four COVID-19 recovery patterns and their impact, namely, “V”, “L”, “W” and “U” are discussed in this report.
Application • COVID-19 • Human Immunodeficiency Virus (HIV) • Healthcare-Associated Infections (HAIs) • Hepatitis • Human Papillomavirus (HPV) • Tuberculosis (TB) • Influenza • Other Infectious Diseases
Application • Diagnostic Laboratories • Hospitals & Clinics • Research Institutes • Home Care Settings • Other End Users
In addition to the revenue predictions for the overall world market and segments, you will also find revenue forecasts for five regional and 19 leading national markets:
North America • U.S. • Canada
Europe • Germany • UK • France • Spain • Italy • Rest of Europe
Asia Pacific • China • Japan • India • Australia • South Korea • Rest of Asia Pacific
Latin America • Brazil • Mexico • Rest of Latin America
The report also includes profiles and for some of the leading companies in the Infectious Disease Diagnostics Market, 2022 to 2032, with a focus on this segment of these companies’ operations.
Leading companies and the potential for market growth • Abbott • Alere Inc. • BioMérieux SA • Becton, Dickinson and Company • Cepheid, Inc. • Co-Diagnostics • Chembio Diagnostic Systems • Danaher Corporation • DiaSorin S.p.A. • ELITechGroup • Epitope Diagnostics • F. Hoffmann-La Roche • Hologic, Inc. • Grifols S.A. • Genetic Signatures Ltd. • InBios International • Meridian Bioscience • Ortho Clinical Diagnostics Holdings plc • OraSure Technologies • PerkinElmer Inc. • Siemens Healthineers • Sysmex Corporation • Thermo Fisher Scientific • Trinity Biotech Plc. • Trivitron Healthcare • Uniogen Oy • Vela Diagnostics • Meril Life Sciences Pvt. Ltd • Quidel Corporation.
Overall world revenue for Infectious Disease Diagnostics Market, 2022 to 2032 in terms of value the market will surpass US$ 29,940.3 million in 2022, our work calculates. We predict strong revenue growth through to 2032. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.
How will the Infectious Disease Diagnostics Market, 2022 to 2032 report help you? In summary, our 320+ page report provides you with the following knowledge:
• Revenue forecasts to 2032 for Infectious Disease Diagnostics Market, 2022 to 2032 Market, with forecasts for type and company size, each forecast at a global and regional level – discover the industry’s prospects, finding the most lucrative places for investments and revenues.
• Revenue forecasts to 2032 for five regional and 19 key national markets – See forecasts for the Infectious Disease Diagnostics Market, 2022 to 2032 market in North America, Europe, Asia-Pacific, Latin America, and MEA. Also forecasted is the market in the US, Canada, Mexico, Brazil, Germany, France, UK, Italy, China, India, Japan, and Australia among other prominent economies.
• Prospects for established firms and those seeking to enter the market – including company profiles for 10 of the major companies involved in the Infectious Disease Diagnostics Market, 2022 to 2032.
Find quantitative and qualitative analyses with independent predictions. Receive information that only our report contains, staying informed with invaluable business intelligence.
Information found nowhere else With our new report, you are less likely to fall behind in knowledge or miss out on opportunities. See how our work could benefit your research, analyses, and decisions. Visiongain’s study is for everybody needing commercial analyses for the Infectious Disease Diagnostics Market, 2022 to 2032, market-leading companies. You will find data, trends and predictions.
Buy our report today Infectious Disease Diagnostics Market Report 2022-2032: Forecasts by Product (Instrument, Reagents, Kits, & Consumables, Software & Services), by Type of Testing (Laboratory Testing and POC Testing), by Technology (Immunodiagnostics, Polymerase Chain Reaction (PCR), DNA Sequencing And Next-Generation Sequencing (NGS), Clinical Microbiology, Other), by Application (COVID-19, Human Immunodeficiency Virus (HIV), Healthcare-Associated Infections (HAIs), Hepatitis, Human Papillomavirus (HPV), Tuberculosis (TB), Influenza, Other), by End-user (Diagnostic Laboratories, Hospitals & Clinics, Research Institutes, Home Care Settings, Other) AND Regional and Leading National Market Analysis PLUS Analysis of Leading Companies AND COVID-19 Impact and Recovery Pattern Analysis. Avoid missing out by staying informed – order our report now.
Visiongain is a trading partner with the US Federal Government CCR Ref number: KD4R6
Do you have any custom requirements we can help you with? Any need for a specific country, geo region, market segment or specific company information? Contact us today, we can discuss your needs and see how we can help: contactus@visiongain.com
1. Report Overview 1.1 Objectives of the Study 1.2 Introduction to Infectious Disease Diagnostics Market 1.3 What This Report Delivers 1.4 Why You Should Read This Report 1.5 Key Questions Answered by This Analytical Report 1.6 Who is This Report for? 1.7 Methodology 1.7.1 Market Definitions 1.7.2 Market Evaluation & Forecasting Methodology 1.7.3 Data Validation 1.7.3.1 Primary Research 1.7.3.2 Secondary Research 1.8 Frequently Asked Questions (FAQs) 1.9 Associated Visiongain Reports 1.10 About Visiongain
2 Executive Summary
3 Market Overview 3.1 Key Findings 3.2 Market Dynamics 3.2.1 Market Driving Factors 3.2.1.1 Growing Prevalence of Infectious Diseases 3.2.1.2 Shift in Focus from Centralized Laboratories to Decentralized POC Testing 3.2.1.3 Increase in Funding from Private & Government Organizations for Diagnostic Service Center 3.2.2 Market Restraining Factors 3.2.2.1 Unfavourable Reimbursement Scenario 3.2.2.2 Shortage of Skilled Professionals 3.2.3 Market Opportunities 3.2.3.1 Growing opportunities in growing economies 3.2.3.2 Introduction of cost-effective and reliable test kits 3.3 COVID-19 Impact Analysis 3.4 Porter’s Five Forces Analysis 3.4.1 Bargaining Power of Suppliers 3.4.2 Bargaining Power of Buyers 3.4.3 Competitive Rivalry 3.4.4 Threat from Substitutes 3.4.5 Threat of New Entrants 3.5 PEST Analysis
4 Infectious Disease Diagnostics Market Analysis by Product 4.1 Key Findings 4.2 Product Segment Growth Prospects 4.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 4.4 Instrument 4.4.1 Market Size by Region, 2022-2032 (US$ Million) 4.4.2 Market Share by Region, 2022 & 2032 (%) 4.5 Reagents, Kits, and Consumables 4.5.1 Market Size by Region, 2022-2032 (US$ Million) 4.5.2 Market Share by Region, 2022 & 2032 (%) 4.6 Software & Services 4.6.1 Market Size by Region, 2022-2032 (US$ Million) 4.6.2 Market Share by Region, 2022 & 2032 (%)
5 Infectious Disease Diagnostics Market Analysis by Type of Testing 5.1 Key Findings 5.2 Type of Testing Segment Growth Prospects 5.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 5.4 Laboratory Testing 5.4.1 Market Size by Region, 2022-2032 (US$ Million) 5.4.2 Market Share by Region, 2022 & 2032 (%) 5.5 POC Testing 5.5.1 Market Size by Region, 2022-2032 (US$ Million) 5.5.2 Market Share by Region, 2022 & 2032 (%)
6 Infectious Disease Diagnostics Market Analysis by Technology 6.1 Key Findings 6.2 Technology Segment Growth Prospects 6.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 6.4 Immunodiagnostics 6.4.1 Market Size by Region, 2022-2032 (US$ Million) 6.4.2 Market Share by Region, 2022 & 2032 (%) 6.6 Polymerase Chain Reaction (PCR) 6.6.1 Market Size by Region, 2022-2032 (US$ Million) 6.6.2 Market Share by Region, 2022 & 2032 (%) 6.7 DNA Sequencing and Next-Generation Sequencing (NGS) 6.7.1 Market Size by Region, 2022-2032 (US$ Million) 6.7.2 Market Share by Region, 2022 & 2032 (%) 6.8 Clinical Microbiology 6.8.1 Market Size by Region, 2022-2032 (US$ Million) 6.8.2 Market Share by Region, 2022 & 2032 (%) 6.9 Other technologies 6.9.1 Market Size by Region, 2022-2032 (US$ Million) 6.9.2 Market Share by Region, 2022 & 2032 (%)
7 Infectious Disease Diagnostics Market Analysis by Application 7.1 Key Findings 7.2 Application Segment Growth Prospects 7.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 7.4 COVID-19 7.4.1 Market Size by Region, 2022-2032 (US$ Million) 7.4.2 Market Share by Region, 2022 & 2032 (%) 7.5 Human Immunodeficiency Virus (HIV) 7.5.1 Market Size by Region, 2022-2032 (US$ Million) 7.5.2 Market Share by Region, 2022 & 2032 (%) 7.6 Healthcare-Associated Infections (HAIs) 7.6.2 Market Share by Region, 2022 & 2032 (%) 7.7 Hepatitis 7.7.1 Market Size by Region, 2022-2032 (US$ Million) 7.7.2 Market Share by Region, 2022 & 2032 (%) 7.8 Human Papillomavirus (HPV) 7.8.2 Market Share by Region, 2022 & 2032 (%) 7.9 Tuberculosis (TB) 7.9.1 Market Size by Region, 2022-2032 (US$ Million) 7.9.2 Market Share by Region, 2022 & 2032 (%) 7.10 Influenza 7.10.1 Market Size by Region, 2022-2032 (US$ Million) 7.10.2 Market Share by Region, 2022 & 2032 (%) 7.11 Other Infectious Diseases 7.11.1 Market Size by Region, 2022-2032 (US$ Million) 7.11.2 Market Share by Region, 2022 & 2032 (%)
8 Infectious Disease Diagnostics Market Analysis by End User 8.1 Key Findings 8.2 End User Segment Growth Prospects 8.3 Infectious Disease Diagnostics Market Size Estimation and Forecast by End User 8.4 Diagnostic Laboratories 8.4.2 Market Share by Region, 2022 & 2032 (%) 8.5 Hospitals & Clinics 8.5.1 Market Size by Region, 2022-2032 (US$ Million) 8.5.2 Market Share by Region, 2022 & 2032 (%) 8.6 Research Institutes 8.6.1 Market Size by Region, 2022-2032 (US$ Million) 8.6.2 Market Share by Region, 2022 & 2032 (%) 8.7 Home Care Settings 8.7.1 Market Size by Region, 2022-2032 (US$ Million) 8.7.2 Market Share by Region, 2022 & 2032 (%) 8.8 Other End Users 8.8.1 Market Size by Region, 2022-2032 (US$ Million) 8.8.2 Market Share by Region, 2022 & 2032 (%)
9 Infectious Disease Diagnostics Market Analysis by Region 9.1 Key Findings 9.2 Regional Market Size Estimation and Forecast 9.3 COVID-19 Impact Analysis: Recovery Scenarios (V, U, W, L)
10 North America Infectious Disease Diagnostics Market Analysis 10.1 Key Findings 10.2 North America Infectious Disease Diagnostics Market Attractiveness Index 10.3 North America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million) 10.4 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country 10.5 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 10.6 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 10.7 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 10.8 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 10.9 North America Infectious Disease Diagnostics Market Size Estimation and Forecast by End users 10.10 U.S. Infectious Disease Diagnostics Market Analysis 10.11 Canada Infectious Disease Diagnostics Market Analysis
11 Europe Infectious Disease Diagnostics Market Analysis 11.1 Key Findings 11.2 Europe Infectious Disease Diagnostics Market Attractiveness Index 11.3 Europe Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million) 11.4 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Country 11.5 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 11.6 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 11.7 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 11.8 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 11.9 Europe Infectious Disease Diagnostics Market Size Estimation and Forecast by End User 11.10 Germany Infectious Disease Diagnostics Market Analysis 11.11 UK Infectious Disease Diagnostics Market Analysis 11.12 France Infectious Disease Diagnostics Market Analysis 11.12 Italy Infectious Disease Diagnostics Market Analysis 11.13 Spain Infectious Disease Diagnostics Market Analysis 11.14 Russia Infectious Disease Diagnostics Market Analysis 11.15 Rest of Europe Infectious Disease Diagnostics Market Analysis
12 Asia Pacific Infectious Disease Diagnostics Market Analysis 12.1 Key Findings 12.2 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index 12.3 Asia Pacific Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million) 12.4 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Country 12.5 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 12.6 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 12.7 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 12.8 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 12.9 Asia Pacific Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users 12.10 Japan Infectious Disease Diagnostics Market Analysis 12.11 China Infectious Disease Diagnostics Market Analysis 12.12 India Infectious Disease Diagnostics Market Analysis 12.13 Australia Infectious Disease Diagnostics Market Analysis 12.14 South Korea Infectious Disease Diagnostics Market Analysis 12.15 Rest of Asia Pacific Infectious Disease Diagnostics Market Analysis
13 Latin America Infectious Disease Diagnostics Market Analysis 13.1 Key Findings 13.2 Latin America Infectious Disease Diagnostics Market Attractiveness Index 13.3 Latin America Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million) 13.4 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Country 13.5 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 13.6 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 13.7 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 13.8 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 13.9 Latin America Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users 13.10 Brazil Infectious Disease Diagnostics Market Analysis 13.11 Mexico Infectious Disease Diagnostics Market Analysis 13.12 Rest of Latin America Infectious Disease Diagnostics Market Analysis
14 MEA Infectious Disease Diagnostics Market Analysis 14.1 Key Findings 14.2 MEA Infectious Disease Diagnostics Market Attractiveness Index 14.3 MEA Infectious Disease Diagnostics Market by Country, 2022, 2027 & 2032 (US$ Million) 14.4 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Country 14.5 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Product 14.6 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Type of Testing 14.7 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Technology 14.8 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by Application 14.9 MEA Infectious Disease Diagnostics Market Size Estimation and Forecast by End-users 14.10 GCC Infectious Disease Diagnostics Market Analysis 14.11 South Africa Infectious Disease Diagnostics Market Analysis 14.12 Rest of MEA Infectious Disease Diagnostics Market Analysis
15 Company Profiles 15.1 Competitive Landscape, 2021 15.2 Danaher Corporation 15.2.1 Company Snapshot 15.2.2 Company Overview 15.2.3 Financial Analysis 15.2.3.1 Net Revenue, 2017-2021 15.2.3.2 R&D, 2017-2021 15.2.3.3 Regional Market Shares, 2021 15.2.4 Product Benchmarking 15.2.5 Strategic Outlook 15.3 PerkinElmer Inc. 15.3.1 Company Snapshot 15.3.2 Company Overview 15.3.3 Financial Analysis 15.3.3.1 Net Revenue, 2017-2021 15.3.3.2 R&D, 2017-2021 15.3.3.3 Regional Market Shares, 2021 15.3.4 Product Benchmarking 15.3.5 Strategic Outlook 15.4 Abbott 15.4.1 Company Snapshot 15.4.2 Company Overview 15.4.3 Financial Analysis 15.4.3.1 Net Revenue, 2017-2021 15.4.3.2 R&D, 2017-2021 15.4.3.3 Regional Market Shares, 2021 15.4.4 Product Benchmarking 15.4.5 Strategic Outlook 15.5 BioMérieux SA 15.5.1 Company Snapshot 15.5.2 Company Overview 15.5.3 Financial Analysis 15.5.3.1 Net Revenue, 2017-2021 15.5.3.2 R&D, 2017-2021 15.5.3.3 Regional Market Shares, 2021 15.5.4 Product Benchmarking 15.5.5 Strategic Outlook 15.6 F. Hoffmann-La Roche Ltd 15.6.1 Company Snapshot 15.6.2 Company Overview 15.6.3 Financial Analysis 15.6.3.1 Net Revenue, 2017-2021 15.6.3.2 R&D, 2017-2021 15.6.3.3 Regional Market Shares, 2021 15.6.4 Product Benchmarking 15.6.5 Strategic Outlook 15.7 Becton, Dickinson and Company 15.7.1 Company Snapshot 15.7.2 Company Overview 15.7.3 Financial Analysis 15.7.3.1 Net Revenue, 2017-2021 15.7.3.2 R&D, 2017-2021 15.7.3.3 Regional Market Shares, 2021 15.7.4 Product Benchmarking 15.7.5 Strategic Outlook 15.8 Bio-Rad Laboratories 15.8.1 Company Snapshot 15.8.2 Company Overview 15.8.3 Financial Analysis 15.8.3.1 Net Revenue, 2017-2021 15.8.3.2 R&D, 2017-2021 15.8.3.3 Regional Market Shares, 2021 15.8.4 Product Benchmarking 15.8.5 Strategic Outlook 15.9 Siemens Healthineers 15.9.1 Company Snapshot 15.9.3 Financial Analysis 15.9.3.1 Net Revenue, 2017-2021 15.9.3.2 R&D, 2017-2021 15.9.3.3 Regional Market Shares, 2021 15.9.4 Product Benchmarking 15.9.4 Strategic Outlook 15.10 Thermo Fisher Scientific 15.10.1 Company Snapshot 15.10.2 Company Overview 15.10.3 Financial Analysis 15.10.3.1 Net Revenue, 2017-2021 15.10.3.2 R&D, 2017-2021 15.10.3.3 Regional Market Shares, 2021 15.10.4 Product Benchmarking 15.10.5 Strategic Outlook 15.11 Quidel Corporation 15.11.1 Company Snapshot 15.11.2 Company Overview 15.11.3 Financial Analysis 15.11.3.1 Net Revenue, 2017-2021 15.11.3.2 R&D, 2017-2021 15.11.3.3 Regional Market Shares, 2021 15.11.4 Product Benchmarking 15.11.5 Strategic Outlook
16 Conclusion and Recommendations 16.1 Concluding Remarks from Visiongain 16.2 Recommendations for Market Players
List of Tables Table 1 Infectious Disease Diagnostics Market Snapshot, 2022 & 2032 (US$ million, CAGR %) Table 2 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario Table 3 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario Table 4 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario Table 5 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario Table 6 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 7 Instrument Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 8 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 9 Software & Services Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR %) Table 10 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 11 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 12 POC Testing Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 13 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%) Table 14 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 15 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 16 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 17 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 18 Immunodiagnostics market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 19 Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 20 COVID-19 Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 21 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 23 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 24 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 25 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 26 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 27 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 28 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 29 Global Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%) Table 30 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 31 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 32 Research Institutes Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 33 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 34 Other End Users Market Forecast by Region, 2022-2032 (US$ Million, AGR%, CAGR%) Table 35 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)) Table 36 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “V” Shaped Recovery Scenario Table 37 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “U” Shaped Recovery Scenario Table 38 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “W” Shaped Recovery Scenario Table 39 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR(%)): “L” Shaped Recovery Scenario Table 40 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%) Table 41 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 42 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 43 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR %) Table 44 North America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 45 North America Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ Million, AGR%, CAGR%) Table 46 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 47 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 48 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%) Table 49 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 50 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 51 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%) Table 52 Europe Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 53 Europe Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%) Table 54 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 55 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 56 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 57 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 58 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 59 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 60 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 61 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%) Table 62 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 63 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 64 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%) Table 65 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 66 Asia Pacific Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%) Table 67 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 68 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 69 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 70 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 71 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 72 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 73 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%) Table 74 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 75 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 76 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%) Table 77 Latin America Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 78 Latin America Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%) Table 79 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 80 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 81 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 82 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ Million, AGR%, CAGR%) Table 83 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ Million, AGR%, CAGR%) Table 84 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ Million, AGR%, CAGR%) Table 85 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ Million, AGR%, CAGR%) Table 86 MEA Infectious Disease Diagnostics Market Forecast by Application 2022-2032 (US$ Million, AGR%, CAGR%) Table 87 MEA Infectious Disease Diagnostics Market Forecast by End User 2022-2032 (US$ Million, AGR%, CAGR%) Table 88 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 89 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 90 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ Million, AGR%, CAGR%) Table 91 Danaher Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 92 Danaher Corporation: Product Benchmarking Table 93 Danaher Corporation: Strategic Outlook Table 94 PerkinElmer Inc.: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 95 PerkinElmer Inc.: Product Benchmarking Table 96 PerkinElmer Inc.: Strategic Outlook Table 97 Abbott: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 98 Abbott: Product Benchmarking Table 99 Abbott: Strategic Outlook Table 100 BioMérieux SA: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 101 BioMérieux SA: Product Benchmarking Table 102 BioMérieux SA: Strategic Outlook Table 103 F. Hoffmann-La Roche Ltd: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 104 F. Hoffmann-La Roche Ltd: Product Benchmarking Table 105 F. Hoffmann-La Roche Ltd: Strategic Outlook Table 106 Becton, Dickinson and Company: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 107 Becton, Dickinson and Company: Product Benchmarking Table 108 Becton, Dickinson and Company: Strategic Outlook Table 109 Bio-Rad Laboratories: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 110 Bio-Rad Laboratories: Product Benchmarking Table 111 Bio-Rad Laboratories: Strategic Outlook Table 112 Siemens Healthineers: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 113 Siemens Healthineers: Product Benchmarking Table 114 Siemens Healthineers: Strategic Outlook Table 115 Thermo Fisher Scientific: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 116 Thermo Fisher Scientific: Product Benchmarking Table 117 Thermo Fisher Scientific: Strategic Outlook Table 118 Quidel Corporation: Key Details, (CEO, HQ, Revenue, Founded, No. of Employees, Company Type, Website, Business Segment) Table 119 Quidel Corporation: Product Benchmarking Table 120 Quidel Corporation: Strategic Outlook
List of Figures Figure 1 Global Clinical Trials Supply and Logistics Market Segmentation Figure 2 Infectious Disease Diagnostics Market by Product: Market Attractiveness Index Figure 3 Infectious Disease Diagnostics Market Attractiveness Index by Region Figure 4 Infectious Disease Diagnostics : Market Dynamics Figure 5 Global COVID Impact Analysis: Infectious Disease Diagnostics Market Recovery Scenarios Figure 6 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery 2027 Figure 7 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 8 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 9 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 10 Infectious Disease Diagnostics Market: Porter’s Five Forces Analysis Figure 11 Infectious Disease Diagnostics Market: PEST Analysis Figure 12 Infectious Disease Diagnostics Market Forecast by Product 2022, 2027, 2032 (Revenue, CAGR %) Figure 13 Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 14 Infectious Disease Diagnostics Market Share Forecast by Product, 2022, 2027, 2032 (%) f research laboratories and increased funding from public and private organizations for the development of diagnostic instruments in the pharmaceutical and biotechnology industry, the instruments segment is anticipated to experience significant growth during the forecast period. Figure 15 Instrument Market Forecast by Region, 2022-2032 (US$ million) Figure 16 Instrument Market Share Forecast by Region, 2022 & 2032 (%) Figure 17 Reagents, Kits, and Consumables Market Forecast by Region, 2022-2032 (US$ million) Figure 18 Reagents, Kits, and Consumables Market Share Forecast by Region, 2022 & 2032 (%) Figure 19 Software & Services Market Forecast by Region, 2022-2032 (US$ million) Figure 20 Software & Services Market Share Forecast by Region, 2022 & 2032 (%) Figure 21 Infectious Disease Diagnostics Market Forecast by Type of Testing 2022, 2027, 2032 (Revenue, CAGR %) Figure 22 Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 23 Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022, 2027, 2032 (%) Figure 24 Laboratory Testing Market Forecast by Region, 2022-2032 (US$ million) Figure 25 Laboratory Testing Market Share Forecast by Region, 2022 & 2032 (%) Figure 26 POC Testing Market Forecast by Region, 2022-2032 (US$ million) Figure 27 POC Testing Market Share Forecast by Region, 2022 & 2032 (%) Figure 28 Infectious Disease Diagnostics Market Forecast by Technology 2022, 2027, 2032 (Revenue, CAGR%) Figure 29 Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 30 Infectious Disease Diagnostics Market Share Forecast by Technology, 2022, 2027, 2032 (%) Figure 31 Immunodiagnostics Market Forecast by Region, 2022-2032 (US$ million) Figure 32 Immunodiagnostics Market Share Forecast by Region, 2022 & 2032 (%) Figure 33 Polymerase Chain Reaction (PCR) Market Forecast by Region, 2022-2032 (US$ million) Figure 34 Polymerase Chain Reaction (PCR) Market Share Forecast by Region, 2022 & 2032 (%) Figure 35 DNA Sequencing and Next-Generation Sequencing (NGS) Market Forecast by Region, 2022-2032 (US$ million) Figure 36 DNA Sequencing and Next-Generation Sequencing (NGS) Market Share Forecast by Region, 2022 & 2032 (%) Figure 37 Clinical Microbiology Market Forecast by Region, 2022-2032 (US$ million) Figure 38 Clinical Microbiology Market Share Forecast by Region, 2022 & 2032 (%) Figure 39 Other technologies Market Forecast by Region, 2022-2032 (US$ million) Figure 40 Other technologies Market Share Forecast by Region, 2022 & 2032 (%) Figure 41 Infectious Disease Diagnostics Market Forecast by Application 2022, 2027, 2032 (Revenue, CAGR%) Figure 42 Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 43 Infectious Disease Diagnostics Market Share Forecast by Application, 2022, 2027, 2032 (%) Figure 44 COVID-19 Market Forecast by Region, 2022-2032 (US$ million) Figure 45 COVID-19 Market Share Forecast by Region, 2022 & 2032 (%) Figure 46 Human Immunodeficiency Virus (HIV) Market Forecast by Region, 2022-2032 (US$ million) Figure 47 Human Immunodeficiency Virus (HIV) Market Share Forecast by Region, 2022 & 2032 (%) Figure 48 Healthcare-Associated Infections (HAIs) Market Forecast by Region, 2022-2032 (US$ million) Figure 49 Healthcare-Associated Infections (HAIs) Market Share Forecast by Region, 2022 & 2032 (%) Figure 50 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million) Figure 51 Hepatitis Market Share Forecast by Region, 2022 & 2032 (%) Figure 52 Human Papillomavirus (HPV) Market Forecast by Region, 2022-2032 (US$ million) Figure 53 Human Papillomavirus (HPV) Market Share Forecast by Region, 2022 & 2032 (%) Figure 54 Tuberculosis (TB) Market Forecast by Region, 2022-2032 (US$ million) Figure 55 Tuberculosis (TB) Market Share Forecast by Region, 2022 & 2032 (%) Figure 56 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million) Figure 57 Influenza Market Share Forecast by Region, 2022 & 2032 (%) Figure 58 Other Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million) Figure 59 Other Infectious Diseases Market Share Forecast by Region, 2022 & 2032 (%) Figure 60 Infectious Disease Diagnostics Market Forecast by End User 2022, 2027, 2032 (Revenue, CAGR%) Figure 61 Infectious Disease Diagnostics Market Forecast by End User, 2022-2032 (US$ million) Figure 62 Infectious Disease Diagnostics Market Share Forecast by End User, 2022, 2027, 2032 (%) Figure 63 Diagnostic Laboratories Market Forecast by Region, 2022-2032 (US$ million) Figure 64 Diagnostic Laboratories Market Share Forecast by Region, 2022 & 2032 (%) Figure 65 Hospitals & Clinics Market Forecast by Region, 2022-2032 (US$ million) Figure 66 Hospitals & Clinics Market Share Forecast by Region, 2022 & 2032 (%) Figure 67 Research Institutes Market Forecast by Region, 2022-2032 (US$ million) Figure 68 Research Institutes Market Share Forecast by Region, 2022 & 2032 (%) Figure 69 Infectious Diseases Market Forecast by Region, 2022-2032 (US$ million) Figure 70 Home Care Settings Market Share Forecast by Region, 2022 & 2032 (%) Figure 71 Other End Users Market Forecast by Region, 2022-2032 (US$ million) Figure 72 Other End Users Market Share Forecast by Region, 2022 & 2032 (%) Figure 73 Infectious Disease Diagnostics Market Forecast by Region 2022, 2027, 2032 (Revenue, CAGR%) Figure 74 Infectious Disease Diagnostics Market Share Forecast by Region 2022, 2027, 2032(%) Figure 75 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)) Figure 76 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “V” Shaped Recovery Figure 77 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “U” Shaped Recovery Figure 78 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “W” Shaped Recovery Figure 79 Infectious Disease Diagnostics Market by Region, 2022-2032 (US$ Million, AGR (%), CAGR (%)): “L” Shaped Recovery Figure 80 North America Infectious Disease Diagnostics Market Attractiveness Index Figure 81 North America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million) Figure 82 North America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million) Figure 83 North America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%) Figure 84 North America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 85 North America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%) Figure 86 North America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 87 North America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%) Figure 88 North America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 89 North America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%) Figure 90 North America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 91 North America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%) Figure 92 North America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million) Figure 93 North America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%) Figure 94 U.S. Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 95 Canada Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 96 Europe Infectious Disease Diagnostics Market Attractiveness Index Figure 97 Europe Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million) Figure 98 Europe Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million) Figure 99 Europe Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%) Figure 100 Europe Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 101 Europe Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%) Figure 102 Europe Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 103 Europe Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%) Figure 104 Europe Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 105 Europe Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%) Figure 106 Europe Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 107 Europe Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%) Figure 108 Europe Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million) Figure 109 Europe Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%) Figure 110 Germany Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 111 UK Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 112 France Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 113 Italy Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 114 Spain Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 115 Russia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 116 Rest of Europe Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 117 Asia Pacific Infectious Disease Diagnostics Market Attractiveness Index Figure 118 Asia Pacific Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million) Figure 119 Asia Pacific Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million) Figure 120 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%) Figure 121 Asia Pacific Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 122 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%) Figure 123 Asia Pacific Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 124 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%) Figure 125 Asia Pacific Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 126 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%) Figure 127 Asia Pacific Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 128 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%) Figure 129 Asia Pacific Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million) Figure 130 Asia Pacific Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%) Figure 131 Japan Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 132 China Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 133 India Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 134 Australia Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 135 South Korea Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 136 Rest of Asia Pacific Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 137 Latin America Infectious Disease Diagnostics Market Attractiveness Index Figure 138 Latin America Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million) Figure 139 Latin America Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million) Figure 140 Latin America Infectious Disease Diagnostics Market Share Forecast by Country, 2022 & 2032 (%) Figure 141 Latin America Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 142 Latin America Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%) Figure 143 Latin America Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 144 Latin America Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%) Figure 145 Latin America Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 146 Latin America Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%) Figure 147 Latin America Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 148 Latin America Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%) Figure 149 Latin America Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million) Figure 150 Latin America Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%) Figure 151 Brazil Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 152 Mexico Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 153 Rest of Latin America Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 154 MEA Infectious Disease Diagnostics Market Attractiveness Index Figure 155 MEA Infectious Disease Diagnostics Market by Region, 2022, 2027 & 2032 (US$ million) Figure 156 MEA Infectious Disease Diagnostics Market Forecast by Country, 2022-2032 (US$ million) Figure 157 MEA Figure 158 MEA Infectious Disease Diagnostics Market Forecast by Product, 2022-2032 (US$ million) Figure 159 MEA Infectious Disease Diagnostics Market Share Forecast by Product, 2022 & 2032 (%) Figure 160 MEA Infectious Disease Diagnostics Market Forecast by Type of Testing, 2022-2032 (US$ million) Figure 161 MEA Infectious Disease Diagnostics Market Share Forecast by Type of Testing, 2022 & 2032 (%) Figure 162 MEA Infectious Disease Diagnostics Market Forecast by Technology, 2022-2032 (US$ million) Figure 163 MEA Infectious Disease Diagnostics Market Share Forecast by Technology, 2022 & 2032 (%) Figure 164 MEA Infectious Disease Diagnostics Market Forecast by Application, 2022-2032 (US$ million) Figure 165 MEA Infectious Disease Diagnostics Market Share Forecast by Application, 2022 & 2032 (%) Figure 166 MEA Infectious Disease Diagnostics Market Forecast by End-users, 2022-2032 (US$ million) Figure 167 MEA Infectious Disease Diagnostics Market Share Forecast by End-users, 2022 & 2032 (%) Figure 168 GCC Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 169 South Africa Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 170 Rest of MEA Infectious Disease Diagnostics Market Forecast, 2022-2032 (US$ million, AGR %) Figure 171 Infectious Disease Diagnostics Market: Company Share/Ranking, 2021 Figure 172 Danaher Corporation: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 173 Danaher Corporation: R&D, 2017-2021 (US$ million, AGR%) Figure 174 Danaher Corporation: Regional Market Shares, 2021 Figure 175 PerkinElmer Inc.: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 176 PerkinElmer Inc.: R&D, 2017-2021 (US$ million, AGR%) Figure 177 PerkinElmer Inc.: Regional Market Shares, 2021 Figure 178 Abbott: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 179 Abbott: R&D, 2017-2021 (US$ million, AGR%) Figure 180 Abbott: Regional Market Shares, 2021 Figure 181 BioMérieux SA: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 182 BioMérieux SA: R&D, 2017-2021 (US$ million, AGR%) Figure 183 BioMérieux SA: Regional Market Shares, 2021 Figure 184 F. Hoffmann-La Roche Ltd: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 185 F. Hoffmann-La Roche Ltd: R&D, 2017-2021 (US$ million, AGR%) Figure 186 F. Hoffmann-La Roche Ltd: Regional Market Shares, 2021 Figure 187 Becton, Dickinson and Company: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 188 Becton, Dickinson and Company: R&D, 2017-2021 (US$ million, AGR%) Figure 189 Becton, Dickinson and Company: Regional Market Shares, 2021 Figure 190 Bio-Rad Laboratories: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 191 Bio-Rad Laboratories: R&D, 2017-2021 (US$ million, AGR%) Figure 192 Bio-Rad Laboratories: Regional Market Shares, 2021 Figure 193 Siemens Healthineers: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 194 Siemens Healthineers: R&D, 2017-2021 (US$ million, AGR%) Figure 195 Siemens Healthineers: Regional Market Shares, 2021 Figure 196 Thermo Fisher Scientific: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 197 Thermo Fisher Scientific: R&D, 2017-2021 (US$ million, AGR%) Figure 198 Thermo Fisher Scientific: Regional Market Shares, 2021 Figure 199 Quidel Corporation: Net Revenue, 2017-2021 (US$ million, AGR%) Figure 200 Quidel Corporation: R&D, 2017-2021 (US$ million, AGR%) Figure 201 Quidel Corporation: Regional Market Shares, 2021
List of Companies Profiled in the Report Abbott Laboratories Becton, Dickinson and Company Bio-Rad Laboratories BioMérieux SA Danaher Corporation F. Hoffmann-La Roche Ltd PerkinElmer Inc. Quidel Corporation. Siemens Healthineers Thermo Fisher Scientific
List of Other Companies Mentioned in the Report Alere Inc. Cepheid, Inc. Chembio Diagnostic Systems Co-Diagnostics DiaSorin S.p.A. ELITechGroup Epitope Diagnostics Genetic Signatures Ltd. Grifols S.A. Hologic, Inc. InBios International Meridian Bioscience Meril Life Sciences Pvt. Ltd. OraSure Technologies Ortho Clinical Diagnostics Holdings plc Sysmex Corporation Trinity Biotech Plc. Trivitron Healthcare Uniogen Oy Vela Diagnostics
List of Associations Mentioned in the Report Centers for Disease Control (CDC) National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID) National Library of Medicine Public Agency of Canada The Joint United Nations Programme on HIV/AIDS (UNAIDS) World Health Organization (WHO)
Download sample pages
Complete the form below to download your free sample pages for Infectious Disease Diagnostics Market Report 2022-2032
Visiongain’s reports are based on comprehensive primary and secondary research. Those studies provide global market forecasts (sales by drug and class, with sub-markets and leading nations covered) and analyses of market drivers and restraints (including SWOT analysis) and current pipeline developments. To find out more about our reports methodology, please email sara.peerun@visiongain.com
“Thank you for this Gene Therapy R&D Market report and for how easy the process was. Your colleague was very helpful and the report is just right for my purpose. This is the 2nd good report from Visiongain and a good price.” Dr Luz Chapa Azuella, Mexico
The global AI-based Clinical Trial Solution Providers market was valued at US$1,232.0 million in 2022 and is projected to grow at a CAGR of 23.3% during the forecast period 2023-2033.
The global Single-Use Bioprocessing Probes & Sensors market was valued US$2,493.8 million in 2022 and is projected to grow at a CAGR of 15.2% during the forecast period 2023-2033.
Visiongain Pharma
Visiongain Pharma
Visiongain Pharma
